Fexofenadine hydrochloride orally disintegrating tablet and preparation method thereof

A technology for fexofenadine hydrochloride and oral disintegrating tablets is applied in the field of preparation of fexofenadine hydrochloride oral disintegrating tablets, and can solve the problems of slow onset, low bioavailability, poor disintegration and the like, Achieve the effect of fast absorption, high bioavailability and convenient administration

Inactive Publication Date: 2010-06-30
YANGTZE RIVER PHARMA GRP BEIJING HAIYAN PHARMA
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The dosage forms of fexofenadine products marketed abroad are tablets and capsules, but they have disadvantages such as poor disintegration, slow onset of action and low bioavailability

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Fexofenadine Hydrochloride Orally Disintegrating Tablets Prescription

[0015] Fexofenadine Hydrochloride 60g

[0016] Sodium Carboxymethyl Cellulose 47g

[0017] Mannitol 75g

[0018] Microcrystalline Cellulose 55g

[0019] Acesulfame Potassium 6.2g

[0020] Aspartame 6.2g

[0021] Chocolate essence 8.5g

[0022] Magnesium Stearate 2.1g

[0023] Anhydrous ethanol amount

[0024] A total of 1000 pieces

Embodiment 2

[0026] Fexofenadine Hydrochloride Orally Disintegrating Tablets Prescription

[0027] Fexofenadine Hydrochloride 60g

[0028] Sodium Carboxymethyl Cellulose 55.4g

[0029] Mannitol 75g

[0030] Microcrystalline Cellulose 46.6g

[0031] Acesulfame Potassium 6.2g

[0032] Aspartame 6.2g

[0033] Chocolate essence 8.5g

[0034] Magnesium Stearate 2.1g

[0035] Anhydrous ethanol amount

[0036] A total of 1000 pieces

Embodiment 3

[0038] Fexofenadine Hydrochloride Orally Disintegrating Tablets Prescription

[0039] Fexofenadine Hydrochloride 60g

[0040] Sodium Carboxymethyl Cellulose 65.4g

[0041] Mannitol 65g

[0042] Microcrystalline Cellulose 46.6g

[0043] Acesulfame Potassium 6.2g

[0044] Aspartame 6.2g

[0045] Chocolate essence 8.5g

[0046] Magnesium Stearate 2.1g

[0047] Anhydrous ethanol amount

[0048] A total of 1000 pieces

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation method of fexofenadine hydrochloride orally disintegrating tablets. Based on the advantages of the orally disintegrating tablet preparation formulation, the product not only overcomes the defects of poor disintegration, slow effect, low bioavailability and the like of the preparation formulations on sale in foreign countries, but also fills a gap in the domestic market, thus adapting to the demand of development of market situation. The medicine has important significance in keeping good health of the people and creating economical and social benefits. The product has simple and easy technique and easily obtained raw and auxiliary materials, is suitable for industrial production, and has good application prospect.

Description

technical field [0001] The invention provides a preparation method of fexofenadine hydrochloride orally disintegrating tablets. Background technique [0002] Fexofenadine Hydrochloride belongs to the third-generation antihistamine without sedative effect. It is the active metabolite of terfenadine in the human body and has a good antihistamine H1 receptor effect. It not only retains the non-sedative properties of the parent compound terfenadine, but also does not have the adverse reactions of terfenadine prolonging the QT interval, paroxysmal ventricular tachycardia and other ventricular arrhythmias. It is used for the treatment of chronic idiopathic urticaria and seasonal allergic rhinitis, suitable for the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria in adults and children over six years old, and can effectively relieve the symptoms caused by seasonal allergic rhinitis. Sneezing, runny nose, itchy nose, palate, and throat, itching, red eye symp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/445A61K9/20A61P43/00A61P37/08
Inventor 周津梅石和鹏侯鹏李薇常艳艳刘冬曾丽君何夏宜
Owner YANGTZE RIVER PHARMA GRP BEIJING HAIYAN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products